Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A modified SELEX approach to identify DNA aptamers with binding specificity to the major histocompatibility complex presenting ovalbumin model antigen. | RSC Adv | 2023 | 37936644 | PubTator, text mining | PubMed |
| Expression Pattern of Tumor-associated Antigens in Neuroblastoma: Association With Cytogenetic Features and Survival. | Cancer Diagn Progn | 2023 | 37927813 | PubTator, text mining | PubMed |
| Erratum: A library of cancer testis specific T cell receptors for T cell receptor gene therapy. | Mol Ther Oncolytics | 2023 | 37920174 | PubTator, text mining | PubMed |
| Quantifying the impact of immunotherapy on RNA dynamics in cancer. | J Immunother Cancer | 2023 | 37914385 | PubTator, text mining | PubMed |
| Impact of Heavy Metals on Glioma Tumorigenesis. | Int J Mol Sci | 2023 | 37895109 | PubTator, text mining | PubMed |
| NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology. | NPJ Precis Oncol | 2023 | 37884744 | PubTator, text mining | PubMed |
| Diagnostic performance of anti-MAGEA family protein autoantibodies in esophageal squamous cell carcinoma. | Int Immunopharmacol | 2023 | 37866309 | PubTator, text mining | PubMed |
| A novel prognostic signature and potential therapeutic drugs based on tumor immune microenvironment characterization in breast cancer. | Heliyon | 2023 | 37860520 | PubTator, text mining | PubMed |
| Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities. | Mol Cells | 2023 | 37853684 | PubTator, text mining | PubMed |
| Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer. | Diagnostics (Basel) | 2023 | 37835834 | PubTator, text mining | PubMed |
| Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy. | Int J Mol Sci | 2023 | 37834126 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis of gingivo-buccal oral cancer reveals two dominant cellular programs. | Cancer Sci | 2023 | 37792582 | PubTator, text mining | PubMed |
| Rare giant ovarian metastasis arising from a small primary lung adenocarcinoma: a case report. | Front Surg | 2023 | 37780910 | PubTator, text mining | PubMed |
| mRNA vaccines in disease prevention and treatment. | Signal Transduct Target Ther | 2023 | 37726283 | PubTator, text mining | PubMed |
| FBXW7 in breast cancer: mechanism of action and therapeutic potential. | J Exp Clin Cancer Res | 2023 | 37658431 | PubTator, text mining | PubMed |
| Peptide-based vaccine for cancer therapies. | Front Immunol | 2023 | 37654484 | PubTator, text mining | PubMed |
| Cellular Therapy in NSCLC: Between Myth and Reality. | Curr Oncol Rep | 2023 | 37646900 | PubTator, text mining | PubMed |
| A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma. | Front Oncol | 2023 | 37637064 | PubTator, text mining | PubMed |
| A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma. | Vaccines (Basel) | 2023 | 37631925 | PubTator, text mining | PubMed |
| Modulation of Radiation Doses and Chimeric Antigen Receptor T Cells: A Promising New Weapon in Solid Tumors-A Narrative Review. | J Pers Med | 2023 | 37623511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=5